Lay Summary
Molecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read MorePSC-IBD Bowel Cancer Risk Study Shows Promising Findings
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.
Read MorePromising Leap Forward in Research on PSC and Bile Duct Cancer
New research identifies a marker (COX2) linking lab models to real-world PSC patients, advancing early cancer detection efforts.
Read MoreMajor Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Major Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Read MoreResearch Update: New Clues to PSC Progression
Dr Anthony George shares new insights into immune cells and predicting PSC progression.
Read MoreNew PSC Support Research Uncovers Critical Link Between Liver and Small Intestine
PSC Support funding helps uncover new clues in the small intestine for potential new treatments for primary sclerosing cholangitis.
Read MoreELMWOOD Clinical Trial Update
Latest results shared at international liver conference.
Read MoreTime to Talk About Bile Duct Cancer Risk in PSC
Patient survey results shared at major liver conference.
Read MoreMore Encouraging Data from the INTEGRIS Clinical Trial
Pliant Therapeutics announce latest results from the INTEGRIS Clinical Trial
Read MoreVISTAS Clinical Trial Update
Early positive results from VISTAS trial testing volixibat in PSC
Read More